M.B.B.S Chief Medical Officer and Head of Research and Development · Taysha Gene Therapies, Inc. (TSHA)

Suyash Prasad

A named executive officer of Taysha Gene Therapies in every fiscal year CompBrief holds from FY2020 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$2,231,064

Salary $432,600

FY2020: $4,015,369

2nd of 3 named executive officers at Taysha Gene Therapies by FY2021 total.

3 named officers on file for Taysha Gene Therapies, FY2021

Suyash Prasad’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Taysha Gene Therapies’s whole pay program stands against its peers

  • Taysha Gene Therapies’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TSHA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2022 (DEF 14A).

Free

Get Suyash Prasad’s full pay file as a PDF — free

More than this page: up to 10 years of Suyash’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Suyash Prasad compensation by year

Taysha Gene Therapies Summary Compensation Table · all 2 fiscal years held
In US dollars, as Taysha Gene Therapies reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021
Salary$216,833$432,600
Bonus$0$0
Stock awards$3,668,409—
Option awards—$1,613,721
Non-equity incentive$129,975$181,692
Pension and deferred compensation$0$0
All other$152$3,051
Total$4,015,369$2,231,064

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Taysha Gene Therapies, Inc. DEF 14A filed April 28, 2022, accession 0001193125-22-127828, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Taysha Gene Therapies, Inc. filed document, accession 0001193125-22-127828. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2022.

$4.0M
$2.2M
FY20
FY21
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU501,559$5,843,162—
Option80,000—$31.00

Per the Outstanding Equity Awards at Fiscal Year-End table in Taysha Gene Therapies, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Taysha Gene Therapies’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
RA Session IIPresident, Chief Executive Officer and Director$4,571,200
Suyash Prasad · this pageM.B.B.S Chief Medical Officer and Head of Research and Development$2,231,064
Kamran AlamChief Financial Officer$1,807,521

The full Taysha Gene Therapies compensation record

free company brief

This page is one person within Taysha Gene Therapies's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Taysha Gene Therapies's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Suyash Prasad's compensation dossier · One-time report. No refunds.